Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03496090
Other study ID # DIVERDIET
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 16, 2018
Est. completion date April 16, 2019

Study information

Verified date August 2019
Source Hospital General Universitario Reina Sofía de Murcia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Phase III trial is designed to demonstrate the non-inferiority of a free diet versus a progressive diet in the treatment of acute diverticulitis (AD) without complications. In this study, the effectiveness of the short-term free diet is evaluated, as well as its safety and the quality of life that is perceived in front of the progressive diet.


Description:

The study will be carried out in the General Surgery and Gastroenterology Services of the following centers:

- Hospital General Universitario Reina Sofía

- Hospital General Universitario Morales Meseguer de Murcia.

- Hospital Universitario Santa Lucía de Cartagena.

- Hospital General Universitario de Elche.

- Complejo Hospitalario Torrecárdenas de Almería

All patients with increased temperature and acute abdominal pain, as well as clinical suspicion of AD, will be screened for their potential selection in the study. Basic blood tests (hemogram) and abdominal ultrasound will be performed and these guidelines will be followed: if the results indicate complicated AD, it will be excluded from the study; if uncomplicated DA is suspected, blood CRP will be requested; if CRP is less than 5 mg / dl, it will be included in the study and ambulatory treatment will be indicated; if CRP is greater than 5mg / dl, abdominal CT with intravenous contrast will be requested. Result: uncomplicated DA, it will be included in the study and it will be indicated ambulatory treatment or complicated DA, it will be excluded from the study-; those patients with uncomplicated AD, but with risk factors, hospital admission will be recommended, and they may be offered to participate in the study.

If the patient meets the criteria for admission to the study, the attending physician (surgeon on duty) will inform and invite them to participate and after signing the informed consent, their data will be collected and they will be contacted. the person of the hospital, in charge of guarding the list and randomization codes to assign him the corresponding research group: group 1 (free diet) or group 2 (progressive diet) (Annex III), - this group will be delivered of your printed diet and you will be instructed about it, as well as, to all patients, the annotations of pain control and temperature on ad-hoc sheet. The patient data will be delivered to the investigator / s of the study of each hospital, who will fill in the Data Collection Notebook (DCN) of each patient and program their controls without information of the group to which the patient has been assigned, as In this way, the consultations are carried out with blinding of the evaluator (the investigator who will do the controls will not know to which group the patient has been assigned). They will also be asked a quality of life questionnaire SF-12 (baseline) and they will be asked for a blood test with a complete blood count and CRP for the 3rd day of treatment.

Outpatients will be contacted daily by phone during the first 3 days of treatment by the study investigator and between the 3rd and 4th day will go to outpatient surgery for clinical and analytical control (1st consultation), filling in the DCN. The hospitalized patients will follow the same clinical and analytical control by the plant surgeon and the study investigator, filling in the DCN. They will be asked for new blood tests with CRP for the 7th day of treatment and, in those patients who do not have a colonoscopy in the last 12 months prior to entering the study, an endoscopic study will be requested before 60 days for confirmation of diverticular disease, filling in the DCN. They will be given a new SF-12 quality of life questionnaire that they will fill out on the 7th day of the start of the treatment. They will be cited for a new consultation (2nd consultation) to all patients (outpatients and those who have been hospitalized), 30 days of the beginning of the treatment, with new clinical control and annotation of the last analytical, as well as third and last SF-12 quality of life questionnaire, in the DCN. To conclude, patients who were asked for colonoscopy, will be cited in a final consultation (3rd) 2 months after beginning the treatment with the endoscopic result closing the study, with the last entries in the DCN.

Sample size:

To obtain a power of 80% to reject the null hypothesis Ho: that the difference of proportions p1 and p2 is lower than the non-inferiority limit of -10, and taking into account that the level of significance is 5%, assuming that the proportion of non-treatment failure in both treatment groups is 94.7%, the total number of patients expected to be included in the study is 134 patients, with an expected percentage of dropouts of 5%, which 67 patients will receive treatment through free diet and other 67 patients through progressive diet. The endpoint for the main comparison is the proportion of subjects with a lower treatment failure rate at one month (30 days) of follow-up.

Statistical treatment:

The continuous variables will be summarized using descriptive statistics: mean, standard deviation (SD), median, minimum, maximum, number of observations and number of missing observations. Non-normal continuous data will be presented as maximum, top quartile, median, lowest quartile, minimum and number of observations. The categorical variables will be described using absolute and relative frequencies.

For the comparisons between variables, the bivariate analysis will be used. The scores of each dependent variable will be compared with the independent variables using parametric statistical methods (and nonparametric when the parametric application criteria are not met). When the changes within the same treatment group are analyzed, statistical tests for related or paired samples will be used.

In the event that the variables follow the normal distribution, one or more of the following techniques will be described:

- If a variable is of a quantitative type and the other is categorical, for the comparison of the means with a dichotomous variable, the Student's t test will be used. In cases where the qualitative variable has more than 2 categories, the one-way variance analysis (ANOVA) will be used. In the analysis of the variance of a factor with repeated measures, it will be assumed that the subjects are randomly selected from normal populations with the same variance. Previously, the assumptions of independence, normality and equality of variances will be checked.

In the case that the variables do not follow the normal distribution:

- If one variable is quantitative and the other qualitative, the test to be applied will be the Mann-Whitney U test when the qualitative variable has 2 levels, and the Kruskall-Wallis test if the qualitative measurement is formed by 3 levels or plus.

- If both variables are of the categorical type, a cross-tabulation will be performed (contingency tables) using the Pearson chi-square statistic to test the independence hypothesis or the Fisher test (in 2 x 2 tables) ). An analysis of typed residuals corrected will be carried out in order to interpret the meaning of the association detected.

For the non-inferiority analysis in the main variables, a calculation will be made using the Farrington-Manning score, Miettinen-Nurminen Score and Gart-Nam Score tests, with a significance level of 0.05, and a limit of no- inferiority of 0.10. For the continuous variables, non-inferiority will be evaluated by the difference of means with the Mann-Whitney U and the Wilcoxon test.

All statistical comparisons will be made using statistical tests with a level of significance p = 0.05.


Recruitment information / eligibility

Status Completed
Enrollment 134
Est. completion date April 16, 2019
Est. primary completion date January 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of uncomplicated acute diverticulitis

- Adequate oral tolerance

- Good response to the first emergency treatment measures (analgesics and antibiotic therapy): improvement of pain and decrease in temperature.

- Willing to continue treatment at home under supervision.

- Accept sign informed consent.

Exclusion Criteria:

- Acute complicated diverticulitis (from grade Ib of the modified Hinchey Classification).

- No good response to the first emergency treatment measures (analgesics and antibiotics): maintenance or increase of abdominal pain, persistence of fever, oral intolerance or vomiting, clinical worsening.

- Antibiotic treatment for diverticulitis in the previous month.

- Suspicion of colorectal cancer.

- Pregnant.

- Refuses to sign informed consent.

Study Design


Intervention

Other:
Free diet
Free diet or free demand, being comparable to the normal or zero hospital diet
Progressive diet
Progressive diet for 7 days, liquid diet for the first three days and soft diet without waste, from the 4th to the 7th day.

Locations

Country Name City State
Spain Hospital General Universitario Reina Sofía Murcia

Sponsors (1)

Lead Sponsor Collaborator
Hospital General Universitario Reina Sofía de Murcia

Country where clinical trial is conducted

Spain, 

References & Publications (41)

Alonso J, Regidor E, Barrio G, Prieto L, Rodríguez C, de la Fuente L. [Population reference values of the Spanish version of the Health Questionnaire SF-36]. Med Clin (Barc). 1998 Oct 10;111(11):410-6. Spanish. — View Citation

Andersen JC, Bundgaard L, Elbrønd H, Laurberg S, Walker LR, Støvring J; Danish Surgical Society. Danish national guidelines for treatment of diverticular disease. Dan Med J. 2012 May;59(5):C4453. — View Citation

Andeweg CS, Mulder IM, Felt-Bersma RJ, Verbon A, van der Wilt GJ, van Goor H, Lange JF, Stoker J, Boermeester MA, Bleichrodt RP; Netherlands Society of Surgery; Working group from Netherlands Societies of Internal Medicine, Gastroenterologists, Radiology, — View Citation

Balasubramanian I, Fleming C, Mohan HM, Schmidt K, Haglind E, Winter DC. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160. doi: 10.1159/000450865. Epub 2016 Oct 5. Review. — View Citation

Binda GA, Cuomo R, Laghi A, Nascimbeni R, Serventi A, Bellini D, Gervaz P, Annibale B; Italian Society of Colon and Rectal Surgery. Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) — View Citation

Biondo S, Golda T, Kreisler E, Espin E, Vallribera F, Oteiza F, Codina-Cazador A, Pujadas M, Flor B. Outpatient versus hospitalization management for uncomplicated diverticulitis: a prospective, multicenter randomized clinical trial (DIVER Trial). Ann Sur — View Citation

Biondo S, Lopez Borao J, Millan M, Kreisler E, Jaurrieta E. Current status of the treatment of acute colonic diverticulitis: a systematic review. Colorectal Dis. 2012 Jan;14(1):e1-e11. doi: 10.1111/j.1463-1318.2011.02766.x. Review. — View Citation

Boermeester MA, Humes DJ, Velmahos GC, Søreide K. Contemporary Review of Risk-Stratified Management in Acute Uncomplicated and Complicated Diverticulitis. World J Surg. 2016 Oct;40(10):2537-45. doi: 10.1007/s00268-016-3560-8. Review. — View Citation

Bugiantella W, Rondelli F, Longaroni M, Mariani E, Sanguinetti A, Avenia N. Left colon acute diverticulitis: an update on diagnosis, treatment and prevention. Int J Surg. 2015 Jan;13:157-164. doi: 10.1016/j.ijsu.2014.12.012. Epub 2014 Dec 11. Review. — View Citation

Díez Burón F, Marcos Vidal JM, Baticón Escudero PM, Montes Armenteros A, Bermejo López JC, Merino Garcia M. [Agreement between verbal numerical scale and visual analog scale assessments in monitoring acute postoperative pain]. Rev Esp Anestesiol Reanim. 2 — View Citation

Etzioni DA, Chiu VY, Cannom RR, Burchette RJ, Haigh PI, Abbas MA. Outpatient treatment of acute diverticulitis: rates and predictors of failure. Dis Colon Rectum. 2010 Jun;53(6):861-5. doi: 10.1007/DCR.0b013e3181cdb243. — View Citation

Feingold D, Steele SR, Lee S, Kaiser A, Boushey R, Buie WD, Rafferty JF. Practice parameters for the treatment of sigmoid diverticulitis. Dis Colon Rectum. 2014 Mar;57(3):284-94. doi: 10.1097/DCR.0000000000000075. — View Citation

Ferzoco LB, Raptopoulos V, Silen W. Acute diverticulitis. N Engl J Med. 1998 May 21;338(21):1521-6. Review. — View Citation

Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002 Jun 15;324(7351):1417. Review. — View Citation

Isacson D, Thorisson A, Andreasson K, Nikberg M, Smedh K, Chabok A. Outpatient, non-antibiotic management in acute uncomplicated diverticulitis: a prospective study. Int J Colorectal Dis. 2015 Sep;30(9):1229-34. doi: 10.1007/s00384-015-2258-y. Epub 2015 M — View Citation

Jackson JD, Hammond T. Systematic review: outpatient management of acute uncomplicated diverticulitis. Int J Colorectal Dis. 2014 Jul;29(7):775-81. doi: 10.1007/s00384-014-1900-4. Epub 2014 May 25. Review. — View Citation

Klarenbeek BR, de Korte N, van der Peet DL, Cuesta MA. Review of current classifications for diverticular disease and a translation into clinical practice. Int J Colorectal Dis. 2012 Feb;27(2):207-14. doi: 10.1007/s00384-011-1314-5. Epub 2011 Sep 17. Revi — View Citation

Kruis W, Germer CT, Leifeld L; German Society for Gastroenterology, Digestive and Metabolic Diseases and The German Society for General and Visceral Surgery. Diverticular disease: guidelines of the german society for gastroenterology, digestive and metabo — View Citation

Mäkelä JT, Klintrup K, Takala H, Rautio T. The role of C-reactive protein in prediction of the severity of acute diverticulitis in an emergency unit. Scand J Gastroenterol. 2015 May;50(5):536-41. doi: 10.3109/00365521.2014.999350. Epub 2015 Feb 9. — View Citation

Martín Gil J, Serralta De Colsa D, García Marín A, Vaquero Rodríguez A, Rey Valcárcel C, Pérez Díaz MD, Sanz Sánchez M, Turégano Fuentes F. [Safety and efficiency of ambulatory treatment of acute diverticulitis]. Gastroenterol Hepatol. 2009 Feb;32(2):83-7 — View Citation

Medina-Fernández FJ, Díaz-Jiménez N, Gallardo-Herrera AB, Gómez-Luque I, Garcilazo-Arsimendi DJ, Gómez-Barbadillo J. New trends in the management of diverticulitis and colonic diverticular disease. Rev Esp Enferm Dig. 2015 Mar;107(3):162-70. Review. — View Citation

Mizuki A, Nagata H, Tatemichi M, Kaneda S, Tsukada N, Ishii H, Hibi T. The out-patient management of patients with acute mild-to-moderate colonic diverticulitis. Aliment Pharmacol Ther. 2005 Apr 1;21(7):889-97. — View Citation

Morris AM, Regenbogen SE, Hardiman KM, Hendren S. Sigmoid diverticulitis: a systematic review. JAMA. 2014 Jan 15;311(3):287-97. doi: 10.1001/jama.2013.282025. Review. — View Citation

Moya P, Arroyo A, Pérez-Legaz J, Serrano P, Candela F, Soriano-Irigaray L, Calpena R. Applicability, safety and efficiency of outpatient treatment in uncomplicated diverticulitis. Tech Coloproctol. 2012 Aug;16(4):301-7. doi: 10.1007/s10151-012-0847-0. Epu — View Citation

Nizri E, Spring S, Ben-Yehuda A, Khatib M, Klausner J, Greenberg R. C-reactive protein as a marker of complicated diverticulitis in patients on anti-inflammatory medications. Tech Coloproctol. 2014 Feb;18(2):145-9. doi: 10.1007/s10151-013-1044-5. Epub 201 — View Citation

Park HC, Kim BS, Lee BH. Management of right colonic uncomplicated diverticulitis: outpatient versus inpatient management. World J Surg. 2011 May;35(5):1118-22. doi: 10.1007/s00268-011-1048-0. — View Citation

Peláez N, Pera M, Courtier R, Sánchez J, Gil MJ, Parés D, Grandea L. [Applicability, safety and efficacy of an ambulatory treatment protocol in patients with uncomplicated acute diverticulitis]. Cir Esp. 2006 Dec;80(6):369-72. Spanish. — View Citation

Reynolds IS, Heaney RM, Khan W, Khan IZ, Waldron R, Barry K. The Utility of Neutrophil to Lymphocyte Ratio as a Predictor of Intervention in Acute Diverticulitis. Dig Surg. 2017;34(3):227-232. doi: 10.1159/000450836. Epub 2016 Dec 10. — View Citation

Rosado-Cobián R, Blasco-Segura T, Ferrer-Márquez M, Marín-Ortega H, Pérez-Domínguez L, Biondo S, Roig-Vila JV. Complicated diverticular disease: Position statement on outpatient management, Hartmann's procedure, laparoscopic peritoneal lavage and laparosc — View Citation

Sartelli M, Catena F, Ansaloni L, Coccolini F, Griffiths EA, Abu-Zidan FM, Di Saverio S, Ulrych J, Kluger Y, Ben-Ishay O, Moore FA, Ivatury RR, Coimbra R, Peitzman AB, Leppaniemi A, Fraga GP, Maier RV, Chiara O, Kashuk J, Sakakushev B, Weber DG, Latifi R, — View Citation

Schmidt S, Vilagut G, Garin O, Cunillera O, Tresserras R, Brugulat P, Mompart A, Medina A, Ferrer M, Alonso J. [Reference guidelines for the 12-Item Short-Form Health Survey version 2 based on the Catalan general population]. Med Clin (Barc). 2012 Dec 8;1 — View Citation

Stam MA, Draaisma WA, van de Wall BJ, Bolkenstein HE, Consten EC, Broeders IA. An unrestricted diet for uncomplicated diverticulitis is safe: results of a prospective diverticulitis diet study. Colorectal Dis. 2017 Apr;19(4):372-377. doi: 10.1111/codi.135 — View Citation

Stollman N, Smalley W, Hirano I; AGA Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis. Gastroenterology. 2015 Dec;149(7):1944-9. doi: 10.1053/j.gastro.2015.10.0 — View Citation

Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Aiello F. Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis. J Clin Gastroenterol. 2010 Nov-Dec;44(10):702-6. doi: 10.1097/MCG.0b013e3181dad979. — View Citation

van de Wall BJ, Draaisma WA, van der Kaaij RT, Consten EC, Wiezer MJ, Broeders IA. The value of inflammation markers and body temperature in acute diverticulitis. Colorectal Dis. 2013 May;15(5):621-6. doi: 10.1111/codi.12072. — View Citation

van de Wall BJ, Draaisma WA, van Iersel JJ, van der Kaaij R, Consten EC, Broeders IA. Dietary restrictions for acute diverticulitis: evidence-based or expert opinion? Int J Colorectal Dis. 2013 Sep;28(9):1287-93. doi: 10.1007/s00384-013-1694-9. Epub 2013 — View Citation

van Dijk ST, Rottier SJ, van Geloven AAW, Boermeester MA. Conservative Treatment of Acute Colonic Diverticulitis. Curr Infect Dis Rep. 2017 Sep 23;19(11):44. doi: 10.1007/s11908-017-0600-y. Review. — View Citation

Vennix S, Morton DG, Hahnloser D, Lange JF, Bemelman WA; Research Committee of the European Society of Coloproctocology. Systematic review of evidence and consensus on diverticulitis: an analysis of national and international guidelines. Colorectal Dis. 2 — View Citation

Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J. [The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments]. Gac Sanit. 200 — View Citation

Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar;34(3):220-33. — View Citation

Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83. — View Citation

* Note: There are 41 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Success in the treatment Absence of persistence, increase or recurrence of abdominal pain or fever, transition to a stage higher than that of the modified Hinchey classification (requiring radiological drainage and / or surgical treatment), need for hospital admission (for outpatients) and death attributed to this diagnosis. 30 days
Secondary Pain score The evaluation in each treatment group of pain intensity, using visual analogue scale (VAS) of pain, self-evaluated daily after dinner. Min value 0. Max value 10. Higher values represent a worse outcome. 7 days
Secondary Body temperature Axillary temperature curve, as a reference, by one shot every 12 hours. 7 days
Secondary PCR value The comparison in each treatment group of the levels of C-reactive protein (CRP). day 0, 3 and 7
Secondary Increase in stage Percentage of patients in each treatment group who pass to a stage higher than Ia in the Hinchey classification modified. 30 days
Secondary Need for hospital admission Percentage of outpatients in each treatment group who require hospital admission. 30 days
See also
  Status Clinical Trial Phase
Completed NCT03700736 - The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Recruiting NCT03682640 - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes Phase 2
Terminated NCT02047136 - Dietary Treatment for Chronic Urticaria N/A
Active, not recruiting NCT05544461 - Piloting a Web-based Personalised Nutrition App (eNutri) With UK University Students N/A
Completed NCT03290118 - The Efficacy of Front-of-package Labelling Schemes: an Experimental Study N/A
Suspended NCT04124016 - Metabotypes in the Urinary Excretion of Flavan-3-ol Metabolites: "Metanols" N/A
Completed NCT03457688 - Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children N/A
Completed NCT03241355 - Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children N/A
Recruiting NCT04616482 - Therapeutic Nutrition With Technology in Primary Care
Recruiting NCT04401605 - Fermented Food-Supplemented Diet in Ulcerative Colitis N/A
Completed NCT03697317 - Televideo Exercise and Nutrition Program for Kidney Transplant Recipients N/A
Completed NCT03748056 - Targeted Food Incentives to Improve Diet Quality and Health Among Adults N/A
Not yet recruiting NCT03657316 - Impact of School Based Education Program N/A
Completed NCT03934476 - The Effects of Lowering Dietary Carbohydrates on Health, Exercise Performance and Wellbeing-related Outcomes N/A
Completed NCT03255603 - Gastrointestinal Assessment of Three Novel RS4 N/A
Completed NCT03129581 - Metabolic Impact of Time Restricted Feeding N/A
Completed NCT03716479 - Gum Acacia and Blood Glucose N/A